Laparoscopic Heller myotomy for achalasia: changing trend toward "true" day-case procedure. by Agrawal, Sanjay & Super, Paul
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
Volume 18, Number 6, 2008
© Mary Ann Liebert, Inc.
DOI: 10.1089/lap.2008.0057
Laparoscopic Heller Myotomy for Achalasia: 
Changing Trend Toward “True” Day-Case Procedure
Sanjay Agrawal, FRCS, and Paul Super, FRCS
Abstract
Background: Laparoscopic Heller myotomy is the most effective therapy for achalasia. All case series have re-
ported a minimum length of stay of more than 1 day. “True” day-case laparoscopic Heller myotomy has not
been reported, so far. The aim of this study was to review our results with laparoscopic Heller myotomy with
respect to the length of stay following the procedure.
Methods: All patients undergoing laparoscopic Heller myotomy between August 2000 and July 2007 under the
care of one surgeon were included in the study. This was performed by incising 6 cm of distal esophageal mus-
culature, extending to 2 cm below the gastroesophageal junction. The myotomy was covered by an anterior
fundoplication. All patients were reviewed in the clinic at a median of 6 weeks after surgery and, thereafter, if
necessary.
Results: Over the 7-year period, 24 consecutive patients with achalasia were treated in this manner. There were
13 women and 11 men, with an age range of 12–73 years. Intraoperative complications included mucosal per-
foration in 2 patients (sutured immediately) with no postoperative complications or conversion to open sur-
gery. There were no deaths. The average length of stay was 1.9 days (range, 0–4). The last 2 patients were dis-
charged on the same day, and the 5 previous to this were discharged within 23 hours of surgery. There were
no adverse outcomes related to early discharge, and there were no readmissions. All patients reported good to
excellent results with a relief of dysphagia on follow-up. Three patients (12%) developed recurrent dysphagia
after an initial improvement, requiring dilatation only several months later.
Conclusions: Based on our own experience, we believe that laparoscopic Heller myotomy with anterior partial
fundoplication is safe and achieves a good outcome in the treatment of achalasia. It is well tolerated and can
be considered a true day-case procedure.
785
Introduction
ESOPHAGEAL ACHALASIA is a rare motility disorder of theesophagus, affecting 1 in 100,000 individuals. It is a be-
nign condition resulting from a loss of ganglion cells in the
myenteric plexus controlling the relaxation of the tonically
contracted lower esophageal sphincter (LES), although the
precise etiology is unknown. Patients present at any age,
from childhood to old age, with dysphagia, regurgitation of
old food, and occasionally, with chest pain. The diagnosis is
confirmed by a combination of barium studies, manometry,
and videoendoscopy. Manometry is the most reliable diag-
nostic tool showing a hypertensive nonrelaxing LES. Aperi-
stalsis or vigorous, uncoordinated contractions of the
esophageal body are the associated manometric findings.
The treatment for achalasia involves reducing LES pressure
to improve esophageal emptying. The various techniques
can be grouped into three approaches: 1) pharmacologic ma-
nipulation of the LES; 2) dilatation or stretching of the LES;
and 3) surgical disruption of the LES.
Heller first described cardiomyotomy for the treatment of
achalasia in 1914,1 using an abdominal approach with an an-
terior and posterior esophageal myotomy. This approach
was modified to a single myotomy by the Dutch surgeon,
Zaaijer, in 1923.2 Laparoscopic cardiomyotomy was first re-
ported in 1991 by Shimi et al.3 The laparoscopic approach to
myotomy is the preferred surgical approach today, as it re-
duces pain, scarring, and is associated with a shorter hospi-
tal stay. All case series have reported a minimum length of
stay of more than 1 day. “True” day-case laparoscopic Heller
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myotomy (i.e., without an overnight admission) has not been
reported in the world literature, so far. The aim of this study
was to review our results with laparoscopic Heller myotomy
and anterior partial fundoplication for achalasia, especially
with respect to the length of stay following the procedure.
Materials and Methods
All patients undergoing laparoscopic Heller myotomy
with anterior partial fundoplication between August 2000
and July 2007 were included in the study. Preoperative work-
up included a barium swallow study or upper gastrointesti-
nal endoscopy or both, along with esophageal manometry
to confirm the diagnosis of achalasia. Before presentation to
us, 9 (37.5%) patients had previous nonoperative treatment.
They included 8 patients who had undergone pneumatic di-
latation and 1 patient who had a botulinum toxin (Botox) in-
jection. One patient had previously been treated with a cal-
cium-channel antagonist (nifedipine) as well. None of our
patients had prior myotomy. A printed information leaflet
was given to all patients in the outpatient clinic following an
explanation of the procedure and the potential complica-
tions. All patients were seen at a preassessment clinic 1–2
weeks before surgery.
All procedures were performed by a single consultant or
a senior trainee supervised by the consultant. The surgical
procedure was laparoscopic Heller myotomy with anterior
partial fundoplication in all patients, using a five-port tech-
nique. The phrenoesophageal ligament was divided, expos-
ing the anterior esophagus and cardia. The esophageal fat
pad was then excised. Laparoscopic Heller myotomy was
performed by incising the distal 6 cm of distal esophageal
musculature, using cautery scissors or, more recently, by ul-
trasonic scalpel extended 2 cm below the gastroesophageal
junction, using hook cautery. Longitudinal and circular mus-
cle fibres were carefully divided until the submucosal plane
was adequately identified. All patients underwent anterior
partial fundoplication by rolling the fundus over the exposed
mucosa to complete the procedure. Three interrupted su-
tures were placed between the fundus of the stomach and
the cut edge of the muscularis to the left of the esophagus,
and then three sutures were placed back down the cut mus-
cularis on the right side of the esophagus. Intraoperative en-
doscopy was not performed as part of the procedure. All
port sites were injected with 0.5% bupivacaine local anaes-
thetic toward the end of the procedure. All patients received
a single dose of prophylactic antibiotics at anesthetic induc-
tion and wore antithromboembolism stockings.
For the patients who underwent the operation as a day-
case procedure, the inclusion criteria were American Society
of Anesthesiologist (ASA) grade I–II and adequate home
support, defined as the presence of a responsible adult carer
for the first 24 hour after the operation. They were admitted
to a dedicated adult day surgery unit at 8 AM on the day of
surgery. Before discharge, patients were reviewed by the sur-
geon and were allowed home once ambulant and with con-
trol of postoperative nausea and pain.
On discharge, patients were given a standard package of
analgesics, consisting of paracetamol (1 g 4 times daily), di-
clofenac (50 mg 3 times daily), and codeine phosphate (30–60
mg 4 times daily), for 5 days. Arrangements were made for
a nurse from the day-surgery unit to contact the day-surgery
patients by telephone on the following day to check on their
progress. All patients were reviewed in the outpatient clinic
at a median of 6 weeks after surgery and, thereafter, if nec-
essary.
Results
Over the 7-year period, 24 consecutive patients with acha-
lasia were treated with laparoscopic Heller myotomy and
anterior partial fundoplication. The patients (13 women and
11 men) ranged in age from 12 to 73 years (median, 42). In-
traoperative complications included mucosal perforation in
2 patients, which were recognized and repaired immediately
with no leak on the postoperative water-soluble contrast
swallow on the next day. No additional procedures were per-
formed. There were no conversions to an open operation.
There were no postoperative complications, and no periop-
erative deaths occurred.
The average length of postoperative stay was 1.9 days
(range, 0–4). The last 2 patients were discharged on the same
day, and the 5 previous to this were discharged within 23
hours of surgery. There were no adverse outcomes related
to early discharge, and there were no readmissions. Both the
day-surgery patients expressed complete satisfaction with
day-care treatment. All patients reported good to excellent
results with relief of dysphagia on follow-up at a median of
6-weeks. Three patients (12%) developed recurrent dyspha-
gia after an initial improvement, requiring dilatations only.
One patient (4.2%) complained of acid reflux postopera-
tively, requiring a proton pump inhibitor.
Discussion
The management of choice for achalasia remains contro-
versial. Multiple treatments exist, including pneumatic di-
latation, Botox injection, or surgical myotomy. Because of the
rarity of achalasia, there is a paucity of randomized, con-
trolled trials comparing the different treatments with most
available data derived from relatively small case series from
specialist centers. Historically, dilatation has been the most
popular method to treat achalasia. This involves pneumatic
dilatation with a balloon to disrupt the circular muscle fibers
of the LES, rendering it incompetent. After balloon dilata-
tion, good symptomatic relief has been reported for 76–96%
of patients in large case series,4–7 especially with repeated
treatments.5–8,11,12 However, it is associated with a 2–7% per-
foration rate and a death rate of 1–2%.8,9 Laparoscopic my-
otomy, in our series, has not been associated with any post-
operative complications or deaths. More recently, the Botox
injection has been used endoscopically to inhibit the release
of acetylcholine from the presynaptic nerve endings leading
to paralysis of the LES. However, the technique has now
largely been abandoned due to poor long-term results, when
compared to balloon dilatation.10–12
Surgical myotomy divides the sphincter muscle and has
long been a treatment option for achalasia. Two series have
confirmed equivalent efficacy and safety of the laparoscopic
approach, when compared with those of open Heller my-
otomy.13,14 The laparoscopic approach to myotomy is the
preferred surgical approach today, as it reduces pain, scar-
ring, and is associated with a shorter hospital stay. However,
as with most advanced laparoscopic procedures, a substan-
tial learning curve is associated with laparoscopic Heller
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myotomy to prevent intraoperative complications or con-
version to an open procedure.15 With experience, we find
that there is no need to mobilize the entire esophagus and
disrupt all of the posterior and lateral attachments of the
esophagus and cardia: Only the anterior phrenoesophageal
fat pad needs to be incised to expose the anterior esophagus
to perform an adequate myotomy. We have observed that
adequate extension of the myotomy onto the gastric cardia
is important in terms of the relief of dysphagia.
Pneumatic dilatation has been identified as a specific risk
factor for complication with laparoscopic Heller my-
otomy.16–18 Some researchers have reported similar prob-
lems following Botox injections.18 We have noticed that the
gastroesophageal junction is much more scarred in patients
who have been dilated or treated with Botox, resulting in a
much more difficult dissection in the submuscular plane
over the mucosa. In our series, one of the two perforations
occurred in a patient who had undergone pneumatic dilata-
tion. However, 8 other patients who had a previous pneu-
matic dilatation or Botox injection developed no intra- or
postoperative complications. We do not believe that previ-
ous pneumatic dilatation carries a necessarily increased risk
of mucosal perforation at the time of Heller myotomy, but
the dissection is more tedious with poor tissue-plane delin-
eation. This observation has been described by others.15,19 A
recently published long-term prospective study that specif-
ically investigated the effect of myotomy in patients whose
symptoms had failed to respond to repeated pneumatic di-
latations concluded that previous dilatation affected neither
the surgical technique nor the outcome.20
Only 2 patients in our series underwent a water-soluble
contrast study the morning after the procedure. Both had a
mucosal perforation that was recognized and repaired in-
traoperatively with no leak on the study. We do not rou-
tinely perform a contrast study on the next day after the op-
eration. However, we believe that a low threshold should be
kept for performing a water-soluble contrast study, if the pa-
tient exhibits an unusual amount of postoperative pain,
tachycardia, or fever.
There is now very good evidence from two randomized,
clinical trials of cardiomyotomy with and without fundopli-
cation that the addition of fundoplication reduces pathologic
reflux by 13–38% without any interference in postoperative
subjective or objective dysphagia outcome.21,22 We routinely
perform anterior partial fundoplication as the antireflux pro-
cedure to a Heller myotomy for achalasia. The advantages
of the anterior fundoplication are that it does not angulate
the distal esophagus like the Toupet, and it does not require
the extensive dissection at the gastroesophageal junction, as
described before. This minimal dissection preserves the an-
gle of His and may help minimize postoperative reflux.23 In
our series, only 1 (4%) patient complained of postoperative
acid reflux requiring medical treatment. In addition, there is
a mechanical benefit gained by the gastric serosa supporting
the exposed esophageal mucosa at the myotomy site.
The most important outcome for the patient with achala-
sia is relief of dysphagia. Twenty-one of our patients (88%)
reported good to excellent results with relief of dysphagia
on follow-up, with no recurrence in our series. In our series,
the last 7 patients were discharged safely within 23 hours of
surgery, with the last 2 on the same day as a true day-case
procedure. There were no adverse outcomes related to early
discharge, and there were no readmissions. All case series in
the world literature have reported a minimum length of hos-
pital stay of more than 1 day, with none thus far reporting
a true day-case laparoscopic Heller myotomy.
Conclusions
Based on our own experience, we believe that laparoscopic
Heller myotomy with anterior partial fundoplication is safe
and achieves a good outcome in the treatment of achalasia.
With the exception of the very frail and infirm patient, in our
unit, laparoscopic Heller myotomy is now considered the
first-line therapy in the treatment of achalasia. It is well tol-
erated and can be considered a true day-case procedure.
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